Skip to main content
All lobbying filings

Mr. David Friedman

Mr. David Friedman filed a Q3 termination report for Teva Pharmaceuticals USA, Inc. on October 20, 2026, reporting no lobbying activity.

Lobbying for Teva Pharmaceuticals USA, Inc. · Pharmaceutical manufacturer.

As filed: MR. DAVID FRIEDMAN for TEVA PHARMACEUTICALS USA, INC.

All filings by Mr. David Friedman · Everything Teva Pharmaceuticals USA, Inc. has reported

 Filing · LD-2 quarterly report Q3 terminationNo activity
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 20, 2026
Income
$50,000
What the client paid this registrant for the period.
Client based in
New Jersey
Representation ended
Jul 30, 2026
The registrant reported terminating its work for this client.

Official filing document

 Lobbying activity 0

No itemized activity in this filing.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem